We found 181 records for "Preclinical research"

Articles

Malaria is biting back: new insecticides are desperately needed

26th February 2015

 Malaria is biting back: new insecticides are desperately neededArticles

Just as resistance to antibiotics is threatening our future health, the rise of insecticide-resistant mosquitoes could halt progress against malaria. New insecticides are desperately needed, and public-private partnerships can deliver...

Read more

Broadening the RWD conversation

26th November 2014

 Broadening the RWD conversationArticles

There can be few pharma CEOs who are not acutely aware of the data revolution exploding around them and the need to enhance their data analytics capabilities. But technical expertise...

Read more

How can pharma innovate in childhood and TYA cancer?

14th November 2014

 How can pharma innovate in childhood and TYA cancer? Articles

As cancers in children and teenagers are rare, there is little commercial incentive for pharma to invest in researching drugs in this sector. Dr Tim Ringrose speaks to specialist in...

Read more

Pre-competitive research: Don’t compete - collaborate!

6th November 2014

 Pre-competitive research: Don’t compete - collaborate!Articles

Pharma and other stakeholders in the health arena are increasingly aware of the benefits of working together in the pre-competitive phase to address common problems. The Pistoia Alliance works to...

Read more

News

Roche to use ‘open innovation’ to develop nanotechnology diagnostics

25th February 2015

 Roche to use ‘open innovation’ to develop nanotechnology diagnosticsNews

Roche has announced a new 'open innovation' research alliance in nanotechnology to develop new diagnostic tools.The Swiss company is to work with BioMed X, a new open innovation lab in...

Read more

AZ taps Orca for oral T cell inhibitors

25th February 2015

 AZ taps Orca for oral T cell inhibitorsNews

AstraZeneca (AZ) has forged an R&D alliance with Orca Pharmaceuticals focusing on the development of a new class of compound with potential in autoimmune disease therapy.UK-based Orca was formed in...

Read more

Don't oversell 100,000 genomes project, experts warn

30th January 2015

 Don't oversell 100,000 genomes project, experts warnNews

The UK's much-vaunted 100,000 genomes project is a ground-breaking initiative, but significant obstacles remain before it can have an impact on patient care, according to experts.Life Sciences Minister George Freeman...

Read more

AZ puts genome editing at heart of its drug discovery

29th January 2015

 AZ puts genome editing at heart of its drug discoveryNews

AstraZeneca (AZ) has become the latest big pharma company to become excited by the prospect of gene editing techniques, signing four new deals to deploy the technology across its drug...

Read more

White Papers

Connected data and the use of smartphone enabled apps in market research

11th July 2014

 Connected data and the use of smartphone enabled apps in market researchWhite Papers

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise...

Read more

Personalised Medicine – the Future of Blockbuster Pharma?

29th October 2013

 Personalised Medicine – the Future of Blockbuster Pharma?White Papers

The personalised medicine approach is rapidly becoming the new norm for pharmaceutical industry drug development and commercialisation, but it demands much more forward-thinking decision-making, as Phenestra outlines in its latest...

Read more

Round table transcript: Oncology shaping the future of personalised healthcare

2nd October 2013

 Round table transcript: Oncology shaping the future of personalised healthcareWhite Papers

Earlier this year pharmaphorum filmed a round table debate exploring how developments in personalised healthcare cancer treatments are defining the future for this area beyond oncology. In this white paper,...

Read more

Audio & Video

Part three: Oncology shaping the future of personalised healthcare

  In the third part of our video round table debate on how oncology is shaping the future of personalised healthcare, the expert panel focusses on the critical role that pharmaceutical...

Read more

Part two: Oncology shaping the future of personalised healthcare

  Continuing our round table debate on how oncology is shaping the future of personalised healthcare, the participants discuss how healthcare systems need to adapt to support delivery of targeted medicines...

Read more

Events

6th Biosimilars Congregation 2015

10th March 2015 - 11th March 2015

6th Biosimilars Congregation 2015

6th Biosimilars Congregation 2015 “Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars” 10th & 11th March 2015, The Kensington Close Hotel, Wrights Lane, London,...

Read more

Patients as Partners 2015

16th March 2015 - 17th March 2015

Patients as Partners 2015

Sponsors have a greater than ever commitment to partner with patients, but the reality is there are limitations and barriers – such as HIPAA, to name just one of many....

Read more

Therapeutic Antibodies: Discovery, Engineering and Development International Masterclass

17th March 2015 - 18th March 2015

Therapeutic Antibodies: Discovery, Engineering and Development International Masterclass

Today's wealth of knowledge of protein structures will be reviewed along with the genetics of diversity generation of antibodies, to give insights into the best strategies for improving protein function. Key...

Read more

Clinical Trials in MENA & Turkey Forum

17th March 2015 - 18th March 2015

Clinical Trials in MENA & Turkey Forum

Shift of Clinical trials from west countries to other regions is trendy and aims mainly to improve patients’ inclusion, to reduce costs and to explore the potential of the emerging...

Read more

Press Releases

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

5th February 2014

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

  Ashfield Commercial & Medical Services   redefines healthcare outsourcing to meet pharma’s challenges   03 February 2014: UDG Healthcare plc (formerly United Drug plc), a leading international provider of services to healthcare manufacturers...

Read more

Unique round table debate brings together key personalised healthcare stakeholders

1st October 2013

Unique round table debate brings together key personalised healthcare stakeholders

AstraZeneca and pharmaphorum media today announced the publication of a unique piece of thought leadership research, via a video round table debate entitled ‘Oncology shaping the future of personalised healthcare’,...

Read more